Form 4 for SNPS Synopsys
Accepted 2022-12-06 00:00:00 ET · period of report 2022-12-02 · accession 0001199719-22-000092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-06 | 2022-12-02 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | S - Sale+OE | $348.97 | -3,465 | 22.7K | -13% | -$1.21M |
| DM | 2022-12-06 | 2022-12-02 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | M - OptEx | $134.44 | +3,465 | 23.2K | +18% | +$465.8K |
| DM | 2022-12-06 | 2022-12-02 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | M - OptEx | $0.00 | -3,465 | 7,860 | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-02 | S | D | 1,323 | $348.97 | 22,675 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-02 | M | A | 1,323 | $89.76 | 23,998 | D | — | — | |
| 3 | Common | Common Stock | 2022-12-02 | S | D | 1,572 | $348.97 | 22,675 | D | — | — | |
| 4 | Common | Common Stock | 2022-12-02 | M | A | 1,572 | $135.88 | 24,247 | D | — | — | |
| 5 | Common | Common Stock | 2022-12-02 | S | D | 570 | $348.97 | 22,675 | D | — | — | |
| 6 | Common | Common Stock | 2022-12-02 | M | A | 570 | $234.17 | 23,245 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-12-02 | M | D | 570 | $0.00 | 5,125 | D | $234.17 · 2021-12-10 to 2027-12-10 | 570 Common Stock | (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-12-02 | M | D | 1,323 | $0.00 | 1,323 | D | $89.76 · 2019-12-12 to 2025-12-12 | 1,323 Common Stock | (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-12-02 | M | D | 1,572 | $0.00 | 7,860 | D | $135.88 · 2020-12-12 to 2026-12-12 | 1,572 Common Stock | (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |